StockWatch
·

Max India Ltd Q1 FY27 Results

MAXINDQ1 FY27 Results
Filing
Result:Weak· Market: DownOne-off hitBase effect
MetricValueQ4 FY26Q1 FY26
Revenue59.74 Cr9.0%62.9%
Total Income68.62 Cr4.8%66.0%
Expenditure103.65 Cr16.6%40.4%
PBT-35.06 Cr105.4%42.6%
Net Profit-36.28 Cr88.1%41.5%
OPM-56.66%36.21pp2.20pp
NPM-52.87%26.09pp9.15pp
EPS6.9188.3%27.0%
View full financials

Loss widened YoY on an adjusted basis (~8% ex the prior-year one-off) with core segment losses (Care Home, Assisted Care) deepening despite strong topline growth, so it stays a below-par print though NPM improved YoY off a low base.

Q1 FY-2027 RESULTS · MAXINDIA

Max India: consolidated loss widens to ₹36.3 Cr YoY despite 63% revenue growth

PAT -41.5% YoY · revenue +62.9% · margins expanding

11 Aug 2026 · 3 min read
Revenue

₹59.74 Cr

+62.9% YoY

PAT (consolidated)

₹-36.28 Cr

-41.5% YoY

Net margin

-52.87%

+9.2pp YoY

EPS

₹-6.91

Max India's consolidated net loss widened to ₹36.28 Cr in Q1 FY27 from ₹25.64 Cr a year ago (+41.5% YoY) and from ₹19.29 Cr last quarter (+88% QoQ), even as consolidated revenue from operations grew 62.9% YoY to ₹59.74 Cr. But the raw YoY comparison is distorted: Q1 FY26's loss was cushioned by a ₹7.88 Cr one-off gain on the sale of three Max Towers floors, which does not recur this quarter (only a token ₹0.03 Cr rights-issue expense sits below the line now). Stripping that one-off out on both sides, the underlying loss widened from ~₹33.5 Cr to ₹36.25 Cr — an adjusted YoY increase of roughly 8%, a materially steadier picture than the headline 41.5% jump. No street estimates for Max India specifically were found in a search of Q1 FY27 preview coverage (searches returned only Max Healthcare Institute and MCX previews), so vs-street is unknown; there is no analyst-poll benchmark to grade this print against.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹59.74 Cr-9%+62.9%
Expenses₹103.65 Cr+16.6%+40.4%
PAT₹-36.28 Cr-88.08%-41.5%
Net margin-52.87%-26.1pp+9.2pp
EPS₹-6.91-288.3%-227%

The quarter is broadly consistent with management's May 2026 concall guidance of 'continued strong revenue growth across business verticals' — Senior Living revenue rose 125.7% YoY to ₹29.41 Cr and Assisted Care rose 42.9% YoY to ₹29.79 Cr. But the guided path to segment profitability is not yet visible: the Assisted Care Products segment loss widened to ₹15.84 Cr from ₹11.67 Cr YoY, and Care Home & Services slipped to a ₹2.92 Cr loss from ₹2.53 Cr last quarter and ₹2.08 Cr a year ago — moving away from, not toward, the H1 FY28 Care Homes breakeven target and the FY27 AGEasy-segment breakeven goal, though both timelines remain some quarters out. Unallocable Assisted Care expenditure also jumped to ₹4.61 Cr from ₹1.04 Cr YoY. Consolidated NPM improved YoY to -52.9% from -62.0% (revenue scaling faster than the loss), but compressed sharply QoQ from -26.8%, because Q4 FY26 carried a ₹13.32 Cr Senior Living segment profit — a lumpy, project-completion-driven swing typical of residential real estate revenue recognition — that did not repeat this quarter (Senior Living posted a ₹3.04 Cr segment loss in Q1 FY27). No management press release was available in the source set to cross-check against the company's own framing of the quarter.

147.2157.65168.11178.56189.0117005-0806-0106-2307-1608-0708-11Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹170, up 1.2% over the past month of trading.

₹ Cr
-51.62-34.41-17.210-46.09Q4 FY25rev ₹42 Cr-25.64Q1 FY26rev ₹37 Cr-34.07Q2 FY26rev ₹45 Cr-42.85Q3 FY26rev ₹43 Cr-19.29Q4 FY26rev ₹66 Cr-36.28Q1 FY27rev ₹60 Cr
Quarterly consolidated PAT, ₹ Crore
What management guided (4 FY-2026 call)
Management provided guidance indicating continued strong revenue growth across business verticals, with a clear commitment to achieving EBITDA breakeven in specific segments like AGEasy by the end of the fiscal year and for Care Homes by H1 FY28. The company is strategically focused on accelerating residential unit sal

This quarter: met

Standalone tells a materially different story than consolidated: the holding company itself swung from a ₹5.71 Cr profit in Q1 FY26 (largely the ₹7.88 Cr property-sale gain) to a ₹3.78 Cr loss this quarter, a divergence explained entirely by that one-off, not by any change in the holdco's core cost base (standalone opex actually fell YoY). Two corporate actions this quarter tie into the funding of the growth push: the ₹80.35 Cr preferential warrant conversion (36.2 lakh shares) completed July 23, 2026, and a ₹25 Cr corporate guarantee extended for a subsidiary loan on July 28, 2026, both channelling capital into Antara's senior-living and assisted-care build-out; Antara separately launched robotic rehabilitation services in Bengaluru on July 17, 2026, an incremental Assisted Care initiative not yet reflected in segment profitability.

  • W1

    Assisted Care Products segment loss (₹15.84 Cr this quarter vs ₹11.67 Cr YoY) against management's FY27 EBITDA-breakeven guidance for AGEasy — needs a clear narrowing path over the next two quarters.

  • W2

    Care Home & Services segment loss (₹2.92 Cr, widened from ₹2.53 Cr QoQ and ₹2.08 Cr YoY) against the H1 FY28 breakeven target — no sequential improvement visible yet.

  • W3

    Senior Living segment-result lumpiness — swung from a ₹13.32 Cr profit in Q4 FY26 to a ₹3.04 Cr loss in Q1 FY27; watch whether residential unit sales and new project signings reaccelerate recognition in H2 FY27.

Standalone is a pure holding company (investments in subsidiaries); its ₹0.03 Cr rights-issue expense is the only current-quarter exceptional item. Year-ago quarter (Q1 FY26) carried a ₹7.88 Cr one-off gain on the Max Towers floor sale, present in both standalone and consolidated PBT, which flatters the raw YoY comparison. Consolidated PAT includes a ₹0.53 Cr JV (Contend Builders) share of loss, based on unaudited JV interim figures per the auditor's 'Other Matters' note.

Informational and educational content only. Not investment advice.

Max India Ltd (MAXIND) Q1 FY27 Results — StockWatch